Snowball logo
logo
6001_logo

Shanghai Fosun Pharmaceutical Group Co Ltd

600196 SHG
¥24.43+¥0.18  (0.74%)
💡 Click on a row in the table to make it appear on the graph
📊 Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
39,011.243,951.541,399.541,067.241,504.142,314.5
COGS
20,294.423,25621,716.621,425.922,386.321,394.9
Gross Profit
18,716.820,695.519,682.919,641.319,117.820,919.6
Operating Expenses & Income
Operating Income
6,302.64,656.73,307.54,245.12,524.33,516.4
Total Operating Expenses
12,414.216,038.916,375.415,396.216,593.522,470
R&D Expenses
3,990.14,304.24,367.63,679.53,560.54,058.4
Selling General & Admin Expenses
3,226.93,828.14,374.94,283.36,801.19,978.2
Earnings from Continuing Operations
Interest Expense
(852.4)(992.4)(1,361)(1,470.4)(1,301.8)(1,232.3)
Interest Income
233.7282.6363.6373.2300.5222.9
Income Tax Expense
1,066.4626.9369.5656.8864.1458.1
Net Income
Net Income
4,728.73,730.82,386.32,769.93,370.63,476.6
Supplemental
EBIT
2,536.83,420.11,184.32,973.72,524.3-
EBITDA
4,183.75,5413,883.15,513.86,096.5-
In millions of CNY, except % and values per 1 share